Abstract
Chronic venous insufficiency (CVI) is the most common pathology of the peripheral vascular system. One of the main principles of conservative treatment for both small and complicated forms is pharmacotherapy with the use of venoactive drugs. The effectiveness of therapy is largely associated with the choice of phlebotrophic drug. The article discusses approaches to systemic and topical drug therapy depending on the form and stage of CVI.
Highlights
Хроническая венозная недостаточность (ХВН) – самая распространенная патология периферической сосудистой системы
The effectiveness of therapy is largely associated with the choice of phlebotrophic drug
The article discusses approaches to systemic and topical drug therapy depending on the form and stage of Chronic venous insufficiency (CVI)
Summary
Хроническая венозная недостаточность (ХВН) – самая распространенная патология периферической сосудистой системы. Фармакотерапия с использованием веноактивных препаратов – один из основных принципов консервативного лечения как малых, так и осложненных форм. Эффективность терапии во многом связана с выбором флеботропного препарата. Рассмотрены подходы к системной и топической медикаментозной терапии в зависимости от формы и стадии ХВН. Ключевые слова: хроническая венозная недостаточность, веноактивные препараты, ФЛП, МОФФ, диосмин, местное лечение
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Ambulatory surgery: hospital-replacing technologies
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
